Overview

Study of Apremilast in Atopic or Contact Dermatitis

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy of apremilast in patients with recalcitrant atopic or contact dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Tufts Medical Center
Collaborator:
Celgene Corporation
Treatments:
Apremilast
Thalidomide